Oracle Corporation has elected Dr. Tomislav Mihaljevic, CEO of Cleveland Clinic, to its Board of Directors, increasing the board size to 13 members. Dr. Mihaljevic brings extensive healthcare leadership experience, including managing complex clinical organizations and advancing patient care globally. His expertise is expected to support Oracle's efforts in leveraging technology to improve healthcare outcomes. The new board term will last until the next annual stockholder meeting in November 2026.
The Nasdaq Composite fell 1% amid rising oil prices nearing $96 per barrel and climbing U.S. Treasury yields, with the 10-year yield approaching 4.5%. Strong economic data, including robust private hiring and a steady services sector, pushed yields h...
Oracle Corporation's stock has surged over 75% since February, driven by a $553 billion AI-driven backlog and strong 84% growth in Oracle Cloud Infrastructure. Despite this impressive growth, the stock is now considered overvalued, trading at peak mu...
Software stocks have surged back after a significant AI-driven sell-off last year, with the iShares Expanded Tech-Software Sector ETF (IGV) now in positive territory for 2026. Cybersecurity stocks, including CrowdStrike and Palo Alto Networks, are le...
Kuehn Law is investigating Oracle officers for allegedly misleading shareholders about the company's AI infrastructure spending, which reportedly caused large capital expenditures without matching revenue growth. The lawsuit claims this increased spe...
Oracle Corporation announced it will release its fourth quarter fiscal year 2026 earnings on June 10, 2026, after the market closes. The company will hold a conference call and live webcast at 4:00 p.m. Central Time to discuss the results, accessible...
